35-Year Biopharma R&D Vet Takes On His Second Startup
Source: Life Science Leader
By Rob Wright, Chief Editor, Life Science Leader
Follow Me On Twitter @RfwrightLSL
IN 2018, Norbert Bischofberger, Ph.D., received an odd text from biopharma serial entrepreneur Arie Belldegrun, M.D.
The two men had met the year prior when Belldegrun’s company, Kite Pharma, was in the throes of being acquired by Gilead Sciences, where Bischofberger had worked since 1990. The text simply said, “You have to meet Chris W.”
Not only did Bischofberger not know who Chris W. was, he didn’t know why he should meet with him. He also didn’t know that this one text would ultimately change the course of his career.
access the Magazine Article!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Life Science Leader? Subscribe today.
Subscribe to Life Science Leader
X
Subscribe to Life Science Leader
This website uses cookies to ensure you get the best experience on our website. Learn more